Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2013-07-03
2015-11-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Recovery From General Anesthesia
NCT00165971
The Comparability of Bispectral Index and Neurosense During Anesthesia
NCT00910416
Awareness During Blended Anaesthesia
NCT01800578
Reliability of BIS Monitoring in Neurosurgical Patients
NCT01483547
EEG Profiles During General Anesthesia : a Comparative Study Between Sevoflurane and Propofol
NCT02893904
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I=13-15 mildly injured
Patients were divided into 3 groups according to the Glasgow Coma Scores calculated before surgery. use of anesthetic agent were recorded during bispectral index (BIS) monitoring and anesthesia application. we used sevoflurane drug intraoperative.
Group I (n=15)=13-15 mildly injured
Bispectral index (BIS) monitoring
When the patients were taken to the operation table, they were monitored with the BIS. we used sevoflurane drug
Sevoflurane
we used sevoflurane drug at inoperative
Group 2 =9-12 moderately damaged
Patients were divided into 3 groups according to the Glasgow Coma Scores calculated before surgery.use of anesthetic agent were recorded during bispectral index (BIS) monitoring and anesthesia application. we used sevoflurane drug intraoperative.
Group 2 (n=15)=9-12 moderately damaged
Bispectral index (BIS) monitoring
When the patients were taken to the operation table, they were monitored with the BIS. we used sevoflurane drug
Sevoflurane
we used sevoflurane drug at inoperative
Group 3=3-8 severely damaged.
Patients were divided into 3 groups according to the Glasgow Coma Scores calculated before surgery. use of anesthetic agent were recorded during bispectral index (BIS) monitoring and anesthesia application. we used sevoflurane drug intraoperative.
Group 3 (n=15)=3-8 severely damaged.
Bispectral index (BIS) monitoring
When the patients were taken to the operation table, they were monitored with the BIS. we used sevoflurane drug
Sevoflurane
we used sevoflurane drug at inoperative
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bispectral index (BIS) monitoring
When the patients were taken to the operation table, they were monitored with the BIS. we used sevoflurane drug
Sevoflurane
we used sevoflurane drug at inoperative
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA II-III
* intracranial surgery
Exclusion Criteria
* liver and renal failure affecting consciousness level other than intracranial pathology
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Trakya University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sevtap Hekimoglu Sahin
Director, clinical research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TÜTF-GOKAEK 2013/127
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.